Key Events This Week
24 Aug: Stock opens at Rs.152.60, slight decline amid flat Sensex
27 Aug: Price rebounds with 1.08% gain to Rs.153.90 despite Sensex dip
28 Aug: New 52-week high at Rs.163.05 and all-time high near Rs.161.55
28 Aug: Week closes at Rs.160.85, up 5.27% vs Sensex down 0.05%
24 August 2026: Week Begins with Minor Decline Amid Flat Market
Gujarat Kidney & Super Speciality Ltd opened the week at Rs.152.60 on 24 August, down 0.13% from the previous close. This slight dip occurred alongside a marginal 0.12% decline in the Sensex, which closed at 36,770.21. Trading volume was modest at 18,936 shares, reflecting a cautious start to the week. The stock’s performance mirrored the broader market sentiment, which was subdued amid mixed sector cues.
25 August 2026: Continued Pressure Despite Sensex Gains
The stock price edged down further by 0.20% to Rs.152.30 on 25 August, even as the Sensex rebounded with a 0.36% gain to 36,901.03. Volume surged significantly to 97,651 shares, indicating increased trading interest despite the price decline. This divergence suggested some profit-taking or consolidation in Gujarat Kidney & Super Speciality Ltd, while the broader market showed resilience.
26 August 2026: Stabilisation with Minimal Movement
On 26 August, the stock price remained largely flat, slipping just 0.03% to Rs.152.25, with volume declining to 14,953 shares. The Sensex also dipped slightly by 0.03% to 36,890.31. This day marked a pause in the stock’s downward drift, setting the stage for a potential rebound as investors awaited fresh catalysts.
Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.
- - Investment Committee approved
- - 50+ candidates screened
- - Strong post-announcement performance
27 August 2026: Strong Rebound Despite Market Weakness
The stock rebounded sharply on 27 August, gaining 1.08% to close at Rs.153.90. This rise came despite a 0.52% decline in the Sensex to 36,700.18, highlighting the stock’s relative strength. Volume was healthy at 46,356 shares. This positive price action was an early indication of renewed buying interest ahead of the week’s key events.
28 August 2026: New 52-Week and All-Time Highs Propel Stock to Weekly Gains
28 August marked a milestone for Gujarat Kidney & Super Speciality Ltd as it surged to a new 52-week high of Rs.163.05 intraday, closing at Rs.160.85, up 4.52% on the day. This represented a cumulative 6.93% gain over the last two trading sessions. The stock outperformed the Sensex, which rose a modest 0.26% to 36,794.04. The all-time high near Rs.161.55 underscored the stock’s strong momentum within the hospital sector.
Technical indicators supported this bullish trend, with the stock trading above all major moving averages (5, 20, 50, 100, and 200 days). The MACD and Bollinger Bands signalled positive momentum, while the Dow Theory and On-Balance Volume suggested accumulation. Despite a recent downgrade to a ‘Hold’ rating by MarketsMOJO on 24 August, the stock’s price action demonstrated robust investor confidence.
Financially, the company reported net sales of ₹88.12 crores and a profit after tax of ₹13.16 crores for the nine months ending June 2026, with quarterly profit before tax rising 23.1% compared to the previous four-quarter average. These results underpin the stock’s strong performance and justify its premium valuation multiples, including a P/E ratio of 77 times trailing earnings.
Considering Gujarat Kidney & Super Speciality Ltd? Wait! SwitchER has found potentially better options in and beyond. Compare this micro-cap with top-rated alternatives now!
- - Better options discovered
- - + beyond scope
- - Top-rated alternatives ready
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-08-24 | Rs.152.60 | -0.13% | 36,770.21 | -0.12% |
| 2026-08-25 | Rs.152.30 | -0.20% | 36,901.03 | +0.36% |
| 2026-08-26 | Rs.152.25 | -0.03% | 36,890.31 | -0.03% |
| 2026-08-27 | Rs.153.90 | +1.08% | 36,700.18 | -0.52% |
| 2026-08-28 | Rs.160.85 | +4.52% | 36,794.04 | +0.26% |
Key Takeaways
Gujarat Kidney & Super Speciality Ltd’s 5.27% weekly gain significantly outpaced the Sensex’s marginal 0.05% decline, highlighting strong relative performance. The stock’s new 52-week and all-time highs reflect robust technical momentum, supported by trading above all major moving averages and bullish MACD and Bollinger Bands signals.
Financially, the company demonstrated solid growth in net sales and profits for the nine months ending June 2026, with a notable 23.1% increase in quarterly profit before tax. However, valuation multiples remain elevated, with a P/E ratio of 77 times trailing earnings, indicating premium pricing that may temper upside potential.
The recent downgrade to a ‘Hold’ rating by MarketsMOJO suggests a cautious stance despite the strong price action, balancing technical strength with fundamental considerations. The micro-cap status entails higher volatility, which investors should factor into their analysis.
Conclusion
The week ending 28 August 2026 was marked by significant milestones for Gujarat Kidney & Super Speciality Ltd, with the stock reaching new 52-week and all-time highs amid strong financial results and positive technical indicators. The stock’s 5.27% weekly gain and outperformance versus the Sensex underscore its growing prominence within the hospital sector. While valuation remains rich and the rating was recently downgraded to ‘Hold’, the company’s sustained momentum and improving fundamentals highlight its evolving market position. Investors should weigh these factors carefully in the context of the stock’s micro-cap volatility and sector dynamics.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
